Critical care
Which cell-death programs drive septic acute lung injury?
Open access · cc by · source: Europe PMC
This review maps how unbalanced autophagy, ferroptosis, and pyroptosis worsen sepsis-induced ALI and which drugs might retune them.
Study at a glance
- Design
- Other — Narrative mechanistic review of autophagy, ferroptosis, and pyroptosis literature in LPS/CLP sepsis-induced ALI (not a new primary experiment)
- N
- No primary analytic N; synthesizes published LPS/CLP and related studies
- Population
- Published preclinical (and cited clinical framework) literature on sepsis-induced ALI/ARDS
- Outcome
- Mapped death-pathway mechanisms and candidate pharmacologic targets for septic lung injury
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
They argue death-pathway imbalance is central to septic lung injury, list inflammatory mediators/pathways (TNF-α/IL-1β/IL-6; NF-κB, JAK2/STAT3, MAPK, PI3K/Akt/mTOR, Notch), and catalog interventions that can improve LPS/CLP lung injury in cited studies.
Methodology
Authors summarized regulatory networks and experimental evidence (largely LPS/CLP models) for autophagy, ferroptosis, and pyroptosis in sepsis ALI, plus candidate targeted compounds and open challenges.
Limitations
Not a new clinical trial; drug effects are mostly preclinical and not ready as bedside protocols from this paper alone.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Dexmedetomidine can protect mouse kidneys after I/R in an ACSL4/ferroptosis-linked framing.
In a renal ischemia/reperfusion mouse model, dexmedetomidine improved Scr/BUN and was tested as acting by inhibiting ACSL4-linked ferroptosis and inflammation via α2-AR signaling.
Scope note — pathway review across autophagy/ferroptosis/pyroptosis — not the same Dex I/R experiment
Limits the claim's scope: a different population, assay, or outcome.
Sepsis ALI literature treats ferroptosis as one interconnected injury program among others.
A sepsis-induced ALI review argues lung injury may be attenuated by regulating autophagy, ferroptosis, and pyroptosis across shared nodes (including ACSL4 and GPX4-axis signaling).
Evidence for the claim as stated.
A mouse renal I/R pharmacologic result and a sepsis ALI pathway review do not establish how much ferroptosis dominates human critical illness versus apoptosis/pyroptosis.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
A mouse renal I/R pharmacologic result and a sepsis ALI pathway review do not establish how much ferroptosis dominates human critical illness versus apoptosis/pyroptosis.
Related papers in this topic
Same topic cluster — not a recommendation engine.